The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial.
Saved in:
| Title: | The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial. |
|---|---|
| Authors: | Denholm, Justin T.1 (AUTHOR) justin.denholm@mh.org.au, Davis, Joshua2,3 (AUTHOR), Paterson, David4,5 (AUTHOR), Roberts, Jason4,6,7 (AUTHOR), Morpeth, Susan8 (AUTHOR), Snelling, Thomas9 (AUTHOR), Zentner, Dominica10 (AUTHOR), Rees, Megan11 (AUTHOR), O'Sullivan, Matthew12,13 (AUTHOR), Price, David14,15 (AUTHOR), Bowen, Asha16 (AUTHOR), Tong, Steven Y. C.1,2 (AUTHOR), for the ASCOT Investigator Group (AUTHOR), Denholm, Justin (AUTHOR), Tong, Steven (AUTHOR), Anderson, Sue (AUTHOR), McQuilton, Zoe (AUTHOR), Venkatesh, Bala (AUTHOR), Hammond, Naomi (AUTHOR), Jha, Vivekanend (AUTHOR) |
| Source: | Trials. 7/14/2020, Vol. 21 Issue 1, p1-3. 3p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17456215 |
|---|---|
| DOI: | 10.1186/s13063-020-04576-9 |
